• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: SCHIZOPHRENIA

Improving QoL in patients with schizophrenia

December 5, 2018  

Canadian real-world study of aripiprazole LAI in schizophrenia

August 23, 2018  

Use of injectable antipsychotics in bipolar I disorder

June 29, 2018  

Sun avoidance – more harm than good?

December 16, 2016  

APA highlights: Treatment trials in psychiatry

June 22, 2016  

Quality of life in schizophrenia: the QUALIFY trial

October 14, 2015  

Beyond remission: redefining the goal of schizophrenia management

August 4, 2015  

Relapse prevention in first-episode schizophrenia: role of long-acting injectables

January 14, 2015  

Long-acting injectable aripiprazole approved in Canada

August 13, 2014  

APA 2014: New Research – Part 2

July 9, 2014  
1
2
3

Browse by Topic

  • MS (415)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – Part 2 posted on June 12, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • DMT prescribing in Canada – survey results posted on June 6, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions